Open full session page

Biomarkers, pharmacokinetics and kidney allograft outcomes

Abstract Session Kidney
Chairs Toby Coates (AU) · John S. Gill (CA)

Presentations

Oral Presentation
Harry Robertson (AU) 15:30
Autonomous AI pathology and spatial transcriptomics reveal inflammatory niches driving i-IFTA in kidney allografts
Harry Robertson (AU)
Bio Abstract
Karen Sherwood (CA) 15:40
Combined genomic transplant and pharmacogenomic risk assessment for pediatric renal patients using Oxford Nanopore Adaptive Sampling
Karen Sherwood (CA)
Bio Abstract
Mini-Oral Presentation
15:50
A Multicenter Randomized Controlled Trial Of Urine CXCL10 Monitoring Post-Kidney Transplant
Julie Ho (CA)
Bio Abstract
Hossein (Hoss) Tabriziani (US) 15:57
Consistently Low Donor-derived Cell-Free DNA Identifies Allograft Stability In Kidney Transplant Recipients
Hossein (Hoss) Tabriziani (US)
Bio Abstract
16:04
Biopsy-proven recurrent IgA nephropathy after kidney transplantation in a multi-ethnic Southeast Asian cohort
Hersharan Sran (SG)
Bio Abstract
Oral Presentation
Henry H L Wu (AU) 16:11
Evaluating urinary volatile organic compounds as a novel metabolomic biomarker to differentiate between acute tubular necrosis and acute graft rejection following kidney transplantation
Henry H L Wu (AU)
Bio Abstract
Download Postcard (16:9) Download Postcard (1:1)

Share this session

Biomarkers, pharmacokinetics and kidney allograft outcomes

Facebook LinkedIn X / Twitter Email
https://app.tts2026.org/program_view/timeslot/112